Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
A $12 Billion US Deal Pushes India's Sun Pharma Into Big Leagues
For Indian billionaire Dilip Shanghvi, who made his fortune selling cheap generic drugs to the world, it was clear at least more than a decade ago that a shift toward specialty treatments would be key to success in the crowded local market. Last…
SGS Acquires Keystone Bioanalytical, Strengthening End-to-End Drug Development Lifecycle Testing Capabilities for North American Pharma and Biotech Industries
BLOOMFIELD, N.J., May 4, 2026 /CNW/ - SGS, the world's leading testing, inspection and certification company, is pleased to announce that it has acquired Keystone Bioanalytical, a specialized provider of bioanalytical testing services based in…
Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
MOVE-IT met the primary endpoint with statistically significant improvement in gastroparesis symptoms in 20 mg and 40 mg TID doses vs placebo Improvements observed across key symptoms, including nausea, early satiety, post-prandial fullness and…
Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds
For the first time in 16 years, oncology is no longer the largest contributor to late-stage pipeline value, Deloitte has found. Pharma R&D returns for the world's top 20 pharma companies have improved for a third year straight to 7%, driven by…
BridgeBio Pharma (NASDAQ:BBIO) CAO Sells $143,160.00 in Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CAO Maricel Apuli sold 2,000 shares of the company's stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $71.58, for a total transaction of…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down - Should You Sell?
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report)'s share price gapped down prior to trading on Monday. The stock had previously closed at $47.37, but opened at $45.34. Zealand Pharma A/S shares last traded at $45.34, with a volume of 3,000…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Time to Sell?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped down before the market opened on Monday. The stock had previously closed at $23.34, but opened at $22.05. Ascentage Pharma Group International shares last…
The drug-pricing problem no one wants to talk about
For the past year countries have been at odds over how to lower drug prices. As United States President Donald Trump sees it, US prices should drop and other countries' prices should rise to make up for lost pharma revenue. For Swiss authorities…
Orion Corporation: Managers' transactions - Henrik Stenqvist
Orion Corporation: Managers' transactions – Henrik Stenqvist Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion…
Artios Further Expands Leadership Team to Advance Oncology Pipeline and Accelerate Regulatory Execution
Jeremy B. Fitch, MBA, appointed as Chief Business Officer Michael A. Alrutz, J.D., Ph.D., appointed as General Counsel Guy C. Ruble, PharmD, appointed as VP, Regulatory Affairs CAMBRIDGE, United Kingdom and NEW YORK, May 04, 2026 – Artios…
Small Language Models trained for your industry can deliver more for your business
Asked why he robbed banks, the American bank robber Willie Sutton is supposed to have answered, “because that's where the money is.” It's a limited point of view, but logical. I'm seeing a trend among enterprise executives today that…
SCOTUS Gives Temporary Relief to Abortion Pill Manufacturers, Louisiana AG Responds
As RedState reported on Saturday, the Fifth Circuit Court of Appeals ruled that Louisiana has standing in its legal battle to reverse the 2023 changes the Food and Drug Administration (FDA) made to its risk evaluation and mitigation strategy (REMS)…
Ardena Strengthens Executive Team to Drive its Next Phase of Growth
Ghent, Belgium, 4 May 2026 – Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as…
Eli Lilly's (LLY) Weight Loss Pill is Better Than Novo's, Says Jim Cramer
Jim Cramer Commented On Big Market Confusion & Discussed These 20 Stocks. Eli Lilly and Company (NYSE:LLY) is one of the stocks discussed by Jim Cramer. Pharmaceutical giant Eli Lilly and Company (NYSE:LLY) is one of Cramer's favorite stocks in the…
Eli Lilly Just Announced Fantastic News for Shareholders
Eli Lilly 's (LLY +3.30%) broad range of drugs has helped build its success over time, but in recent years, one particular portfolio has supercharged growth. I'm talking about the company's weight loss drugs. The key product is tirzepatide, sold…
Receive a Daily briefing on Pharma Industry News
Get Started